Arctic Bioscience AS
ABS
Rank in Stocks
#29633
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Γrsta, Norway.
Share Price
$0.27120727
Last synced: 2026-11-09
Market Cap
$7.31M
Change (1 day)
7.36%
Change (1 year)
-29.55%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Arctic Bioscience AS (ABS)
Category
Healthcare
EPS for Arctic Bioscience AS (ABS)
EPS as of June 2026 TTM: $-0.16
According to Arctic Bioscience AS's latest financial reports, its current EPS (TTM) is $-0.16. At the end of 2025 the company had an EPS of $-0.15, an increase over its 2024 EPS of $-0.17.
EPS history for Arctic Bioscience AS from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.16 | 7.33% |
| 2025 | $-0.15 | -9.16% |
| 2024 | $-0.17 | -5.69% |
| 2023 | $-0.18 | 22.75% |
| 2022 | $-0.14 | -27.81% |
| 2021 | $-0.20 | 84.31% |
| 2020 | $-0.11 | 482.16% |
| 2019 | $-0.02 | 122.89% |
| 2018 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -9,826.71% |
US
|
|
| $-7.07 | 4,291.30% |
US
|
|
| $-5.29 | 3,185.71% |
AU
|
|
| $12.88 | -8,100.06% |
BE
|
|
| $21.56 | -13,491.30% |
NL
|
Questions about Arctic Bioscience AS's earnings per share (EPS)
What is Arctic Bioscience AS's earnings per share (EPS)?
Arctic Bioscience AS's earnings per share (EPS) over the last twelve months is $-0.16, as of Jun 2026.
What was Arctic Bioscience AS's earnings per share (EPS) in 2025?
In 2025, Arctic Bioscience AS's earnings per share (EPS) was $-0.15, compared with $-0.17 in 2024.
How has Arctic Bioscience AS's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Arctic Bioscience AS's earnings per share (EPS) was highest in 2020 ($-0.11) and lowest in 2021 ($-0.20).
How does Arctic Bioscience AS's earnings per share (EPS) compare with similar companies?
Arctic Bioscience AS's earnings per share (EPS) ($-0.16) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.